Argentine lab strikes deal to produce Russia s Sputnik V vaccine reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
By Eliana Raszewski
BUENOS AIRES, Feb 26 (Reuters) - An Argentine laboratory has struck a deal to help produce Russia s COVID-19 vaccine Sputnik V, according to a company statement shared by the country s government on Friday, helping boost the local firm s share price.
Laboratorios Richmond has signed a memorandum of understanding with Russia s RDIF sovereign wealth fund to be able to manufacture the vaccine, which has so far been the main drug used in Argentina s fledgling inoculation program.
Argentina was one of the first countries in the region to sign an agreement with Russia to buy Sputnik V and has already received 1.22 million doses from the Russian Gamaleya Institute.
Argentine lab says agrees deal to produce Russia s Sputnik V vaccine whbl.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from whbl.com Daily Mail and Mail on Sunday newspapers.